Change from Hybrid to Fully Minimally Invasive and Robotic Esophagectomy is Possible without Compromises

Abstract

Background The incidence of esophageal carcinoma is increasing in the western world, and esophageal resection is the essential therapy. Several studies report advantages of minimally invasive esophagectomies (MIEs) versus conventional open procedures (OPs). The benefits of the use of fully MIE or robot-assisted MIE (RAMIE) compared with the hybrid approaches (laparoscopic gastric preparation and open transthoracic esophagectomy) remain unclear.

Methods Between July 2015 and August 2017, the data of 75 patients with esophageal carcinoma were prospectively registered. Of the 75 patients, 25 treated with a hybrid MIE (hybrid), 25 with total MIE (MIE), and 25 with RAMIE. All patients were operated by the same specialized surgeon in our center with an identical anastomotic technique (circular stapler).

Results The overall 30- and 90-day mortality rates were 0 and 1.33% (1/75), respectively. Total hospital stay (p = 0.262), intensive care unit stay (p = 0.079), number of resected lymph nodes (p = 0.863), and R status (p = 0.132) did not differ statistically between the groups. However, pneumonia and wound infections occurred significantly and more frequently in the hybrid group compared with the minimally invasive groups (MIE and RAMIE) (p = 0.046 and p = 0.003, respectively).

Conclusion Comparable results regarding morbidity and short-term outcome could be achieved in the MIE and RAMIE groups compared with the hybrid group. The data indicate that the learning curve is low in surgeons changing the technique form hybrid esophagectomy to fully MIE. Additionally, the total minimally invasive approaches seem to be associated with a low incidence of complications such as pneumonia and wound infections.

Keywords

Robotics - minimally invasive surgery - port access - minithoracotomy - surgical equipment - esophageal surgery

• References

• 1 Gupta B, Kumar N. Worldwide incidence, mortality and time trends for cancer of the oesophagus. Eur J Cancer Prev 2017; 26 (02) 107-118
• 2 Torre LA, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin 2015; 65 (02) 87-108
• 3 Ferlay J, Soerjomataram I, Dikshit R. , et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer 2015; 136 (05) E359-E386
• 4 Pennathur A, Gibson MK, Jobe BA, Luketich JD. Oesophageal carcinoma. Lancet 2013; 381 (9864): 400-412
• 5 Di Pardo BJ, Bronson NW, Diggs BS, Thomas Jr CR, Hunter JG, Dolan JP. The global burden of esophageal cancer: a disability-adjusted life-year approach. World J Surg 2016; 40 (02) 395-401
• 6 Arnold M, Soerjomataram I, Ferlay J, Forman D. Global incidence of oesophageal cancer by histological subtype in 2012. Gut 2015; 64 (03) 381-387
• 7 Luketich JD, Pennathur A, Awais O. , et al. Outcomes after minimally invasive esophagectomy: review of over 1000 patients. Ann Surg 2012; 256 (01) 95-103
• 8 Grimminger PP, Hadzijusufovic E, Lang H. Robotic-assisted Ivor Lewis esophagectomy (RAMIE) with a standardized intrathoracic circular end-to-side stapled anastomosis and a team of two (surgeon and assistant only). Thorac Cardiovasc Surg 2018; 66 (05) 404-406
• 9 Grimminger PP, Hadzijusufovic E, Ruurda JP, Lang H, van Hillegersberg R. The da Vinci Xi robotic 4-arm approach for robotic-assisted minimally invasive esophagectomy. Thorac Cardiovasc Surg 2018; 66 (05) 407-409
• 10 Biere SS, Maas KW, Bonavina L. , et al. Traditional invasive vs. minimally invasive esophagectomy: a multi-center, randomized trial (TIME-trial). BMC Surg 2011; 11: 2
• 11 Javidfar J, Bacchetta M, Yang JA. , et al. The use of a tailored surgical technique for minimally invasive esophagectomy. J Thorac Cardiovasc Surg 2012; 143 (05) 1125-1129
• 12 Watanabe M, Baba Y, Nagai Y, Baba H. Minimally invasive esophagectomy for esophageal cancer: an updated review. Surg Today 2013; 43 (03) 237-244
• 13 Thirunavukarasu P, Gabriel E, Attwood K, Kukar M, Hochwald SN, Nurkin SJ. Nationwide analysis of short-term surgical outcomes of minimally invasive esophagectomy for malignancy. Int J Surg 2016; 25: 69-75
• 14 Biere SS, van Berge Henegouwen MI, Maas KW. , et al. Minimally invasive versus open oesophagectomy for patients with oesophageal cancer: a multicentre, open-label, randomised controlled trial. Lancet 2012; 379 (9829): 1887-1892
• 15 Grimminger PP, Lang H. Totally minimally invasive esophagectomy and gastric pull-up reconstruction with an intrathoracic circular stapled anastomosis with a team of two (surgeon and assistant only). Thorac Cardiovasc Surg 2018; 66 (05) 401-403
• 16 Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240 (02) 205-213
• 17 Gebski V, Burmeister B, Smithers BM, Foo K, Zalcberg J, Simes J. ; Australasian Gastro-Intestinal Trials Group. Survival benefits from neoadjuvant chemoradiotherapy or chemotherapy in oesophageal carcinoma: a meta-analysis. Lancet Oncol 2007; 8 (03) 226-234
• 18 Wang VS, Hornick JL, Sepulveda JA, Mauer R, Poneros JM. Low prevalence of submucosal invasive carcinoma at esophagectomy for high-grade dysplasia or intramucosal adenocarcinoma in Barrett's esophagus: a 20-year experience. Gastrointest Endosc 2009; 69 (04) 777-783
• 19 Bird-Lieberman EL, Fitzgerald RC. Early diagnosis of oesophageal cancer. Br J Cancer 2009; 101 (01) 1-6
• 20 Blencowe NS, Strong S, McNair AG. , et al. Reporting of short-term clinical outcomes after esophagectomy: a systematic review. Ann Surg 2012; 255 (04) 658-666
• 21 Hummel R, Bausch D. Anastomotic leakage after upper gastrointestinal surgery: surgical treatment. Visc Med 2017; 33 (03) 207-211
• 22 Crestanello JA, Deschamps C, Cassivi SD. , et al. Selective management of intrathoracic anastomotic leak after esophagectomy. J Thorac Cardiovasc Surg 2005; 129 (02) 254-260
• 23 Messager M, Warlaumont M, Renaud F. , et al. Recent improvements in the management of esophageal anastomotic leak after surgery for cancer. Eur J Surg Oncol 2017; 43 (02) 258-269
• 24 Birkmeyer JD, Siewers AE, Finlayson EV. , et al. Hospital volume and surgical mortality in the United States. N Engl J Med 2002; 346 (15) 1128-1137
• 25 Guo W, Zou YB, Ma Z. , et al. One surgeon's learning curve for video-assisted thoracoscopic esophagectomy for esophageal cancer with the patient in lateral position: how many cases are needed to reach competence?. Surg Endosc 2013; 27 (04) 1346-1352
• 26 Tapias LF, Morse CR. Minimally invasive Ivor Lewis esophagectomy: description of a learning curve. J Am Coll Surg 2014; 218 (06) 1130-1140
• 27 van der Sluis PC, Ruurda JP, van der Horst S. , et al. Robot-assisted minimally invasive thoraco-laparoscopic esophagectomy versus open transthoracic esophagectomy for resectable esophageal cancer, a randomized controlled trial (ROBOT trial). Trials 2012; 13: 230
• 28 Ruurda JP, van der Sluis PC, van der Horst S, van Hilllegersberg R. Robot-assisted minimally invasive esophagectomy for esophageal cancer: A systematic review. J Surg Oncol 2015; 112 (03) 257-265
• 29 Mariette C, Markar S, Dabakuyo-Yonli TS. , et al. 615O_PRHybrid minimally invasive vs. open esophagectomy for patients with esophageal cancer: long-term outcomes of a multicenter, open-label, randomized phase III controlled trial, the MIRO trial. Ann Oncol 2017; 28 (05) mdx440.023
• 30 Palazzo F, Rosato EL, Chaudhary A. , et al. Minimally invasive esophagectomy provides significant survival advantage compared with open or hybrid esophagectomy for patients with cancers of the esophagus and gastroesophageal junction. J Am Coll Surg 2015; 220 (04) 672-679